IBS is a disorder of the digestive tract often caused by the absorption of all the potential causative toxic substances, allergens and amines which contribute to the symptoms of IBS.
Bowel Balance is primarily a mineral adsorbant due to its un-absorbable three-dimensional negatively charged micro-porous alumino-silica structure
It has anti-oxidant absorbant properties by means of its potentiated cation exchange capacity and acts as a free-radical scavenger
The Unique Technology of Absorbatox in Bowel Balance Absorbatox has been described as a “super-mop”. It works like a sponge which absorbs (takes up into its structure) certain substances and adsorbs (attracts and causes adhesion) of other substances on its surface. Absorbatox absorbs and adsorbs substances from the gut that can be potentially toxic or harmful to the body.
Since Absorbatox passes through the intestinal system without being systemically absorbed by the body, all toxic material it takes up is eliminated from the body, and their potentially harmful effects are reduced before they can be absorbed into the bloodstream.
MODE OF ACTION
DOSAGE AND DIRECTIONS
FEATURES AND BENEFITS
Brand Manager - OTC
Ground Floor, Tugela House, Riverside Office Park, 1303 Heuwel Avenue, Centurion, 0046
P.O. Box 10458, Centurion, 0046
Telephone: +27 12 643 2024, Fax: +27 12 643 2003
References: 1. Irritable Bowel Syndrome (IBS). The Merck Manual Home Edition. (Last accessed 7 April 2015) From: http://www.merckmanuals.com/home/digestive_ disorders/irritable_bowel_syndrome_ibs/irritable_bowel_syndrome_ibs.html 2. Canavan, C. et al. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014; 6: 71–80. (Last accessed 7 April 2015) From: http://www.ncbi.nlm.nih.gov/pmc/articles/ pmc3921083/ 3. Bowel Balance™ Package Insert; Data on file. Bowel Balance™ Capsules. D 32.16 Others: 33. Minerals. Each capsule contains 700 mg Potentiated Absorbatox® CEC 3.5.IBS. For full prescribing information refer to the package insert. Further information is available on request from the applicant. This medicine has not been evaluated by the Medical Control Council. This medicine is not intended to diagnose, treat, cure or prevent any disease. Applicant: Absorbatox (Pty) Ltd. Marketed by: Ranbaxy (SA) (Pty) Ltd, a Sun Pharma company. Reg. no.: 1993/001413/07. Ground Floor, Tugela House, Riverside Office Park, 1303 Heuwel Avenue, Centurion. Tel: +27 12 643 2000. Website: www.sunpharma.com